- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01114100
The Effects of Treatment With Sertraline for Noncardiac Chest Pain
The Effects of Treatment With Sertraline for Panic Disorder and/or Depression Driven Chest Pain and/or Palpitations in a Double Blind, Care as Usual and Placebo Controlled Study
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Noncardiac chest pain remains an important problem in clinical cardiology. Often, panic disorder and/or depression are the underlying cause. However, this is largely underdiagnosed.
There are no clear existing treatment strategies/methods for this specific patient population.
In our double blind, placebo controlled care as usual versus sertraline study, we want to investigate whether intervention is more effective as care as usual for diminishing chest pain, and also if sertraline is more effective in this specific population compared to placebo.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Fase 4
Kontakter og lokationer
Studiesteder
-
-
-
Maastricht, Holland, 6202 AZ
- Maastricht University Medical Centre
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- chest pain without a cardiac cause
- diagnosed with panic disorder and or depression according to Diagnostic and statistical Manual (DSM) IV criteria
- Living < 50 km from the hospital
- informed consent
Exclusion Criteria:
- other primary DSM IV diagnosis
- known sensitivity to sertraline
- using other anti-depressive agents
- not speaking dutch language
- living in a nursery home or having dementia
- other severe, acute or progressive disease, kidney or liver-function disturbances, pregnancy or breastfeeding
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: sertraline, panic education
treatment with sertraline after panic education
|
starting dose 25 mg for 1 week, the increasing to 50 mg, after each visit evaluation whether dosage has to be increased to maximally 150 mg
Andre navne:
|
Placebo komparator: placebo after panic education
treatment with placebo after panic education
|
patients received 1 pill, according to their complaints the number of pills was increased to maximally 3
|
Ingen indgriben: care as usual
patient received no diagnosis an no panic education, they had a 24 weeks follow up with a visit at 12 weeks and 24 weeks to evaluate their complaints
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
panic attacks
Tidsramme: 24 weeks
|
reduction of panic attacks by more than or equal to 50%
|
24 weeks
|
17 items Hamilton depression (HAMD) rating scale score
Tidsramme: 24 weeks
|
reduction of HAMD score of >50%
|
24 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Hospital Anxiety and Depression Scale (HADS)reduction score
Tidsramme: 24 weeks
|
reduction in Hospital Anxiety and Depression Score
|
24 weeks
|
Clinical Global Impression (CGI) improvement
Tidsramme: 24 weeks
|
improvement in Clinical Global Impression Scale
|
24 weeks
|
EuroQol (EQ-5D)score
Tidsramme: 24 weeks
|
improvement of Quality of Life measured by the EuroQol
|
24 weeks
|
Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) score
Tidsramme: 24 weeks
|
improvement of Quality of Life measured by the SF 36
|
24 weeks
|
health care costs
Tidsramme: 24 weeks
|
decrease of health care costs using a diary for health costs
|
24 weeks
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Efterforskere
- Studiestol: Adriaan Honig, Prof,MD,Phd, Now: St Lucas and Andreas Hospital, Amsterdam, Netherlands
- Ledende efterforsker: Petra Kuijpers, MD, PhD, Maastricht University Medical Centre, Maastricht, the Netherlands
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Adfærdsmæssige symptomer
- Psykiske lidelser
- Stemningsforstyrrelser
- Smerte
- Neurologiske manifestationer
- Angstlidelser
- Depression
- Depressiv lidelse
- Brystsmerter
- Paniklidelse
- Lægemidlers fysiologiske virkninger
- Neurotransmittermidler
- Molekylære mekanismer for farmakologisk virkning
- Psykotropiske stoffer
- Serotoninoptagelseshæmmere
- Neurotransmitter optagelseshæmmere
- Membrantransportmodulatorer
- Serotoninmidler
- Antidepressive midler
- Sertralin
Andre undersøgelses-id-numre
- MEC99-128
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Depression
-
ProgenaBiomeRekrutteringDepression | Depression, postpartum | Depression, angst | Depression Moderat | Depression Alvorlig | Klinisk depression | Depression i remission | Depression, Endogen | Depression KroniskForenede Stater
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRekrutteringDepression | Depression Moderat | Depression Alvorlig | Depression MildForenede Stater
-
Washington University School of MedicineAfsluttetBehandlingsresistent depression | Senlivsdepression | Geriatrisk depression | Refraktær depression | Terapi-resistent depressionForenede Stater, Canada
-
University of California, San FranciscoRekrutteringDepression Moderat | Depression Mild | Depression, teenagerForenede Stater
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RekrutteringDepression Moderat | Depression Alvorlig | Depression MildBelgien
-
Baylor College of MedicineUniversity of TexasRekrutteringDepression | Depression Moderat | Depression Alvorlig | Selvmord og selvskade | Depression i ungdomsårene | Depression MildForenede Stater
-
Charite University, Berlin, GermanyAfsluttetBehandlingsresistent depression | Depression, Unipolar | Depression KroniskTyskland
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoAfsluttetDepression Moderat | Depression MildForenede Stater, Dominikanske republik
-
University of California, San FranciscoIkke rekrutterer endnuDepression Moderat | Depression MildForenede Stater
-
University of BernAfsluttetDepression Moderat | Depression MildSchweiz
Kliniske forsøg med sertraline
-
Beijing HuiLongGuan HospitalAfsluttet
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI)AfsluttetDepression | Myokardieinfarkt | Hjertesygdomme | Hjerte-kar-sygdomme | Angina, ustabilForenede Stater
-
University of Sao PauloAfsluttet
-
Su RuiUkendt
-
Rhode Island HospitalStanford University; University of Cincinnati; American Epilepsy Society; Epilepsy...AfsluttetDepression | Stresslidelser, posttraumatisk | Dissociative lidelser | Konverteringsforstyrrelse | Kramper, ikke-epileptiskForenede Stater
-
TakedaAfsluttetCrohns sygdom | Colitis ulcerosaBelgien, Forenede Stater, Korea, Republikken, Malaysia, Canada, Israel, Australien, Ungarn, Tjekkiet, Tyskland
-
National Institute of Diabetes and Digestive and...Afsluttet
-
National Institute of Mental Health (NIMH)AfsluttetPost-traumatisk stresslidelse | Akut traumatisk stresslidelseForenede Stater
-
Eunice Kennedy Shriver National Institute of Child...AfsluttetPræmenstruelt syndromForenede Stater
-
Eunice Kennedy Shriver National Institute of Child...UkendtSelvskadende adfærd | Kompulsiv adfærd | Mental retardering | Stereotyp adfærdForenede Stater